Janssen OK With Combining Zytiga Suits If They're Sent To NJ
Janssen Biotech told a Virginia federal court that it's fine if several proposed classes want to combine their suits accusing the pharmaceutical company of delaying the entry of a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article